Skip to main content

Revvityブログ

発見から治療までのイノベーションを促進

The significance of longitudinal in vivo imaging in advancing drug discovery.
Small Molecule Drug Discovery November 8, 2024 - 3 min read
NGS
Existing depletion technologies for Next-Generation Sequencing (NGS).
Cancer
Fluorescence imaging is comparable to PET in early detection of tumor metabolism.
Cancer
The top 7 attributes of cell line-derived reference standards for oncology assays.
Cell and Gene Therapy
The future of cell and gene therapy: Revvity at ASGCT.
NGS
Limitations associated with the lack of data analysis tools in metagenomics.
Disease Research
Why use fluorescent probes in your in vivo imaging studies?
Physiological Models
Overcoming the challenges of 3D immune cell-killing assays.
Physiological Models
Making organoids ready for screening.
Precision Medicine
The future of precision medicine: integrating functional approaches for better outcomes.
Precision Medicine
Redefining precision medicine with real-time insights.

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ